GL1X · GenesisL1 explorer

Research workbench

Ctx-M-14 S237A beta-lactamase in complex with a non-covalent tetrazole inhibitor

Analyse Ctx-M-14 S237A beta-lactamase in complex with a non-covalent tetrazole inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6BT6
Type
protein
Length
523 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
A0A1B3B7F6
Ligands
3GK
Pockets
2 · best druggability 0.35

Structure

x-ray diffraction · 2 distinct chains · 44% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein26344% helix, 19% strandA0A1B3B7F6
BBeta-lactamase (EC 3.5.2.6)protein26043% helix, 20% strandA0A1B3B7F6

Ligands and binding sites

  • 3GK · N-[3-(2H-tetrazol-5-yl)phenyl]-6-(trifluoromethyl)-1H-benzimidazole-4-carboxamide · ligand · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1920.350.75223GK
2900.320.74203GK

Interfaces

1 interface between chains.

  • A–B · 129 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 1 modified (cyclization).

Compared structures

  • 6BT6 · CTX-M-14 S237A Beta-Lactamase in Complex with a Non-Covalent Tetrazole Inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.